Viridian Therapeutics, Inc. VRDN shares are up on Tuesday as the company announced positive topline results from its REVEAL-2 ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teprotumumab (Tepezza, Amgen) as the first treatment to be licensed in the UK for adults with moderate-to-severe thyroid eye ...

In the busy pipeline of potential treatments for thyroid eye disease (TED), the novel agent veligrotug showed safety and efficacy in both moderate-to-severe active and chronic TED in the phase 3 ...

Because it's rare and not always top of mind for doctors, TED can quietly progress or be mistaken for allergies or Graves' ...

An injectable monoclonal antibody that targets the insulin-like growth factor I receptor improved proptosis in more than half ...

Raymond Douglas, MD, PhD, is an internationally recognized thyroid eye disease (TED) specialist and board-certified oculoplastic surgeon. Based in Beverly Hills and Las Vegas, he has more than 15 ...

“Over the past few years, with the advent of pharmaceutical therapy for thyroid eye disease, it’s a little more in the forefront. With the marketing and ads on TV, it’s become more commonly discussed, ...

This article was reviewed by Felix Gussone, MD. Thyroid health reflects how well your thyroid gland is functioning as part of your broader endocrine system. The endocrine system is a network of glands ...

Stage 4 papillary thyroid cancer involves distant metastasis, with treatment focusing on disease control and quality of life rather than cure. Diagnostic tools include imaging, biopsy, and molecular ...

Hashimoto encephalopathy is a rare autoimmune condition that causes brain inflammation. It’s linked to thyroid disease and can lead to severe neurological symptoms, but it’s treatable with the proper ...